Introduction
The high flow oxygen therapy is increasingly used in patients with acute respiratory failure. However, an adequate humidification is necessary to improve patient tolerance to this therapy. Few data is available in literature about the hygrometry delivered by these devices.
Objectives
To evaluate hygrometric performances of several high flow oxygen therapy devices and to evaluate the potential clinical impact of different levels of hygrometry.
Methods
We have tested on a bench the hygrometric performance of different oxygen high flow therapy systems (OptiFlow/ Airvo -Fisher&Paykel, Hydrate OMNI -Hydrate inc., Precision flow -Vapoterm,). We have used psychrometric method to measure hygrometry.
For each condition, we made 3 hygrometric measurements at different moments of the day. The measurements were taken proximal to the simulated patient's interface. We have tested different settings (intubation and NIV settings for the Optiflow), different flow rates (10, 20-30-40 and 60l/min) and two ambient temperatures: normal temperature (22-24°C) and high temperature (28-30°C). We evaluated the comfort in 10 healthy subjects blinded for different humidity levels (20, 30 and 40 mgH 2 O/L) during 10 minutes in random orders. In healthy subjects, comfort was equivalent at 30 and 40 mgH2O/L but significantly lower at 20 mgH2O/L.
The main results are presented on the following figures.
Conclusions
With NIV setting, Optiflow delivered low humidity, with lower comfort in the short term evaluation in healthy subjects. In the other conditions, the majority of the tested humidification systems deliver at least 30mgH 2 O/L. At high temperature (28-30°C), the majority of the systems showed a decrease in their hygrometric performance (except Precision flow). The flow rate influence is moderated regarding the humidification performance (except for Vapotherm). The new technology Hydrate performed reasonably well within the tested conditions.
There is no clear recommendations for the level of humidity to deliver during HFOT, but NIV setting may be less comfortable.
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